Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services
- PMID: 33601307
- PMCID: PMC7836733
- DOI: 10.1016/j.puhe.2021.01.004
Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services
Abstract
Objective: The aim of the study was to describe the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on people who inject drugs (PWID) in England, Wales and Northern Ireland.
Study design: This is a cross-sectional Unlinked Anonymous Monitoring (UAM) Survey of PWID.
Methods: People who had ever injected psychoactive drugs were recruited to the UAM Survey by specialist drug/alcohol services in England, Wales and Northern Ireland. From June 2020, in addition to providing a dried blood spot sample and completing the UAM behavioural questionnaire, participants were asked to complete an enhanced coronavirus disease 2019 (COVID-19) questionnaire. Preliminary data are presented to the end of October and were compared with data from the 2019 UAM Survey, where possible.
Results: Between June and October, 288 PWID were recruited from England and Northern Ireland. One in nine (11%; 29/260) PWID reported testing positive for SARS-CoV-2 or experiencing COVID-19 symptoms. Fifteen percent (26/169) reported injecting more frequently in 2020 than in 2019; cocaine injection in the preceding four weeks increased from 17% (242/1456) to 25% (33/130). One in five PWID (19%; 35/188) reported difficulties in accessing HIV and hepatitis testing, and one in four (26%; 47/179) reported difficulties in accessing equipment for safer injecting.
Conclusions: Our preliminary findings suggest that PWID have experienced negative impacts on health, behaviours and access to essential harm reduction, testing and treatment services owing to the COVID-19 pandemic. Continued monitoring through surveillance and research is needed to understand the subsequent impact of COVID-19 on blood-borne virus transmission in this population and on health inequalities.
Keywords: COVID-19; Infectious disease; Outbreak; People who inject drugs; SARS-CoV-2; United Kingdom.
Crown Copyright © 2021. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.Int J Drug Policy. 2022 Nov;109:103821. doi: 10.1016/j.drugpo.2022.103821. Epub 2022 Aug 20. Int J Drug Policy. 2022. PMID: 35994940
-
The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.Int J Drug Policy. 2017 Aug;46:34-40. doi: 10.1016/j.drugpo.2017.05.017. Epub 2017 Jun 3. Int J Drug Policy. 2017. PMID: 28586701
-
Patterns of injecting and non-injecting drug use by sexual behaviour in people who inject drugs attending services in England, Wales and Northern Ireland, 2013-2016.Int J Drug Policy. 2018 May;55:215-221. doi: 10.1016/j.drugpo.2018.02.017. Epub 2018 Mar 6. Int J Drug Policy. 2018. PMID: 29523484
-
Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response.Harm Reduct J. 2020 Dec 1;17(1):95. doi: 10.1186/s12954-020-00445-5. Harm Reduct J. 2020. PMID: 33261636 Free PMC article. Review.
-
Health service utilisation and access for people who inject drugs during COVID-19.Drug Alcohol Rev. 2022 Sep;41(6):1304-1310. doi: 10.1111/dar.13456. Epub 2022 Mar 9. Drug Alcohol Rev. 2022. PMID: 35266229 Free PMC article. Review.
Cited by
-
Impact of SARS-CoV-2 lockdown on expansion of HIV transmission clusters among key populations: A retrospective phylogenetic analysis.Lancet Reg Health Am. 2022 Dec;16:100369. doi: 10.1016/j.lana.2022.100369. Epub 2022 Sep 23. Lancet Reg Health Am. 2022. PMID: 36168656 Free PMC article.
-
Impact of the COVID-19 Pandemic on HIV Test Uptake Among People Who Inject Drugs in the Context of an HIV Outbreak.AIDS Behav. 2024 Jun;28(6):2131-2147. doi: 10.1007/s10461-024-04311-4. Epub 2024 Apr 22. AIDS Behav. 2024. PMID: 38649554 Free PMC article.
-
HIV Care Continuum Services for People Who Inject Drugs in Kazakhstan During COVID-19: A Qualitative Study of Service Provider Perspectives.Glob Health Sci Pract. 2022 Apr 29;10(2):e2100619. doi: 10.9745/GHSP-D-21-00619. Print 2022 Apr 28. Glob Health Sci Pract. 2022. PMID: 35487549 Free PMC article.
-
Is Methadone Safe for Patients With Opioid Use Disorder and Coronavirus Disease 2019 Infection?J Addict Nurs. 2022 Apr-Jun 01;33(2):86-94. doi: 10.1097/JAN.0000000000000457. J Addict Nurs. 2022. PMID: 35640212 Free PMC article.
-
Disproportionate, differential and targeted treatment: people who use drugs' experiences of policing during the COVID-19 pandemic.Health Justice. 2025 Jan 23;13(1):6. doi: 10.1186/s40352-024-00314-4. Health Justice. 2025. PMID: 39847147 Free PMC article.
References
-
- European Monitoring Centre for Drugs and Drug Addiction . EMCDDA; Lisbon: 2020. EMCDDA update on the implications of COVID-19 for people who use drugs (PWUD) and drug service providers.
-
- Public Health England . PHE; London: 2020. Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID: 2020 report.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous